|
May 29
|
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
|
|
May 28
|
US cancels more than $700 million funding for Moderna bird flu vaccine
|
|
May 28
|
Moderna Announces Update on Investigational Pandemic Influenza Program
|
|
May 27
|
Moderna to Present at Upcoming Conferences in June 2025
|
|
May 26
|
Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”
|
|
May 26
|
MRNA Seeks FDA Nod for Updated COVID-19 Vaccine
|
|
May 26
|
COVID Vaccine Makers Catch a Break in FDA Policy Shift
|
|
May 23
|
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review
|
|
May 23
|
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
|
|
May 22
|
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
|
|
May 22
|
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot
|
|
Apr 25
|
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|
|
Apr 24
|
Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 24
|
3 Healthcare Stocks Facing Headwinds
|
|
Apr 24
|
Flagship’s latest venture reflects more than 25 years of leaping into the unknown
|
|
Apr 23
|
Why vaccine makers aren't worried about Trump administration cuts
|
|
Apr 20
|
Where Will Moderna Be in 5 Years?
|
|
Apr 17
|
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Apr 17
|
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
|
|
Apr 17
|
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
|